Removing Barriers to PrEP in Rhode Island
Status: Pending
RI H7625/S2255 prohibits insurers from imposing cost sharing (copays or meeting a deductible) or utilization review (also referred to as utilization management), such as prior authorization or step therapy, for any HIV prevention drug.
Learn more about PrEP and how GLAD is working to expand access to this game-changing HIV prevention medication.
Related Content
-
Improving Access to PrEP in Rhode Island
Read MoreExpanding access to a medication that reduces the risk of HIV transmission by close to 100%.
-
GLAD Testifies in Opposition to Proposed HIV Criminalization Legislation in Rhode Island
Read MoreGLAD AIDS Law Project Director and Senior Staff Attorney Ben Klein testified before the Rhode Island House Judiciary Committee February…